Elevated expression of VEGFR-3 in lymphatic endothelial cells from lymphangiomas

BackgroundLymphangiomas are neoplasias of childhood. Their etiology is unknown and a causal therapy does not exist. The recent discovery of highly specific markers for lymphatic endothelial cells (LECs) has permitted their isolation and characterization, but expression levels and stability of molecular markers on LECs from healthy and lymphangioma tissues have not been studied yet. We addressed this problem by profiling LECs from normal dermis and two children suffering from lymphangioma, and also compared them with blood endothelial cells (BECs) from umbilical vein, aorta and myometrial microvessels.MethodsLymphangioma tissue samples were obtained from two young patients suffering from lymphangioma in the axillary and upper arm region. Initially isolated with anti-CD31 (PECAM-1) antibodies, the cells were separated by FACS sorting and magnetic beads using anti-podoplanin and/or LYVE-1 antibodies. Characterization was performed by FACS analysis, immunofluorescence staining, ELISA and micro-array gene analysis.ResultsLECs from foreskin and lymphangioma had an almost identical pattern of lymphendothelial markers such as podoplanin, Prox1, reelin, cMaf and integrin-α1 and -α9. However, LYVE-1 was down-regulated and VEGFR-2 and R-3 were up-regulated in lymphangiomas. Prox1 was constantly expressed in LECs but not in any of the BECs.ConclusionLECs from different sources express slightly variable molecular markers, but can always be distinguished from BECs by their Prox1 expression. High levels of VEGFR-3 and -2 seem to contribute to the etiology of lymphangiomas.

[1]  H. Augustin,et al.  Intrinsic versus microenvironmental regulation of lymphatic endothelial cell phenotype and function , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  Tatiana V. Petrova,et al.  Lymphangiogenesis in development and human disease , 2005, Nature.

[3]  K. Alitalo,et al.  Immunodetection and quantification of vascular endothelial growth factor receptor‐3 in human malignant tumor tissues , 2004, International journal of cancer.

[4]  K. Alitalo,et al.  Detection, Isolation and Culture of Lymphatic Endothelial Cells , 2004 .

[5]  E. Tschachler,et al.  Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. , 1998, Cancer research.

[6]  T. Libermann,et al.  Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells. , 2003, The American journal of pathology.

[7]  H. Filston.  Hemangiomas, cystic hygromas, and teratomas of the head and neck. , 1994, Seminars in pediatric surgery.

[8]  Ruijin Huang,et al.  Dual origin of avian lymphatics. , 2006, Developmental biology.

[9]  K. Alitalo,et al.  Molecular lymphangiogenesis: new players. , 2005, Trends in cell biology.

[10]  K. Alitalo,et al.  Quantification of vascular endothelial growth factor-C (VEGF-C) by a novel ELISA. , 2004, Journal of immunological methods.

[11]  L. Orci,et al.  Generation and characterization of telomerase-transfected human lymphatic endothelial cells with an extended life span. , 2004, The American journal of pathology.

[12]  T. Kennedy,et al.  Cystic Hygroma/Lymphangioma: A Rational Approach to Management , 2001, The Laryngoscope.

[13]  K. Devriendt,et al.  Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia. , 2003, American journal of human genetics.

[14]  Robert E. Ferrell,et al.  Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema , 2000, Nature Genetics.

[15]  K. Alitalo,et al.  Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox‐1 homeobox transcription factor , 2002, The EMBO journal.

[16]  D. Kerjaschki,et al.  Isolation and Characterization of Dermal Lymphatic and Blood Endothelial Cells Reveal Stable and Functionally Specialized Cell Lineages , 2001, The Journal of experimental medicine.

[17]  K. Devriendt,et al.  Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. , 2000, American journal of human genetics.

[18]  Hsin-Yi Huang,et al.  Co-Expression of VEGF-C and Its Receptors, VEGFR-2 and VEGFR-3, in Endothelial Cells of Lymphangioma. Implication in Autocrine or Paracrine Regulation of Lymphangioma , 2001, Laboratory Investigation.

[19]  P. Campochiaro,et al.  Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. , 2002, Developmental cell.

[20]  J. Sleeman,et al.  Markers for the lymphatic endothelium: In search of the holy grail? , 2001, Microscopy research and technique.

[21]  G. Oliver,et al.  Prox1 Function Is Required for the Development of the Murine Lymphatic System , 1999, Cell.

[22]  E C Nice,et al.  Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF‐C/D receptor VEGFR‐3 , 2001, The EMBO journal.

[23]  S. Hirakawa,et al.  Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate , 2002, Developmental dynamics : an official publication of the American Association of Anatomists.

[24]  S. Hirakawa,et al.  Hepatocyte growth factor promotes lymphatic vessel formation and function , 2005, The EMBO journal.

[25]  H. Augustin.  Methods in Endothelial Cell Biology , 2004, Springer Lab Manuals.

[26]  J. Gershenwald,et al.  Structure function relationships in the lymphatic system and implications for cancer biology , 2006, Cancer and Metastasis Reviews.

[27]  Filston Hc.  Hemangiomas, cystic hygromas, and teratomas of the head and neck. , 1994 .

[28]  Franz M. Enzinger,et al.  Soft Tissue Tumors , 1983 .

[29]  J. Folkman,et al.  Long-term culture of capillary endothelial cells. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[30]  B. Christ,et al.  Development of lymphatic vessels: tumour lymphangiogenesis and lymphatic invasion. , 2005, Current medicinal chemistry.

[31]  D. Jackson,et al.  LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan , 1999, The Journal of cell biology.

[32]  S. Rockson.  Literature watch. Hirakawa S, Hong YK, Harvey N, Schacht V, Matsuda K, Libermann T, Detmar M. Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells. Am J Pathol. 2003; 162:575-86. , 2004, Lymphatic research and biology.

[33]  K. Nicolaides,et al.  The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  K. Alitalo,et al.  Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. Skobe,et al.  Molecular characterization of lymphatic endothelial cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Witte,et al.  Syndromic classification of hereditary lymphedema. , 2003, Lymphology.

[37]  E. Tschachler,et al.  Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. , 1999, The American journal of pathology.

[38]  Henrt Sharp.  VASCULAR BIRTHMARKS , 1953, The Medical journal of Australia.

[39]  K. Wolff,et al.  Immunoelectron Microscopic Characterization of Human Dermal Lymphatic Microvascular Endothelial Cells: Differential Expression of CD31, CD34, and Type IV Collagen with Lymphatic Endothelial Cells vs Blood Capillary Endothelial Cells in Normal Human Skin, Lymphangioma, and Hemangioma In Situ , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[40]  M. W. Glynn,et al.  Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. , 2000, American journal of human genetics.